Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion type Assertion NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_head.
- NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion description "[TCR alpha CDR3 spectratyping showed preferential usage of certain TRAV genes in the PBMCs and TILs of all patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_provenance.
- NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion evidence source_evidence_literature NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_provenance.
- NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion SIO_000772 22862170 NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_provenance.
- NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion wasDerivedFrom befree-20140225 NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_provenance.
- NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_assertion wasGeneratedBy ECO_0000203 NP590039.RAJEq_ZuV1wZ437Afz2u7w5y55-QnQ7VN9bMscJJMSgjU130_provenance.